Amir Nakash

Amir Nakash has an extensive work experience in the pharmaceutical industry. Amir is currently the National Sales Director at Halozyme, Inc. In this role, they lead a team of specialists in the launch of XYOSTED in the Urology/Endocrinology space and has built strategic partnerships for pull-through. Amir also manages national key opinion leaders (KOLs) and leads Advisory Boards for new product launches.

Prior to their current role, Amir held the position of Manager, Northeast Region at Halozyme, Inc. Amir was the winner of the President's Club for three consecutive years and led a team of nine specialists in the launch of XYOSTED. Amir also played a key role in developing training materials and providing leadership for workshops.

Before joining Halozyme, Inc., Amir worked at Publicis as a Healthcare Liaison. Amir was responsible for the successful commercial launch of Orexo's product in the NY metro area and achieved a 6.1% market share for Zubsolv within nine months. Amir also played an instrumental role in the launch of Xeljanz, a novel treatment for RA, in the NYC area.

Earlier in their career, Amir worked as a Pharmaceutical Sales Representative at inVentiv Health Commercial and as a Research Analyst at Khandaker Partners.

Overall, Amir Nakash has demonstrated strong leadership skills, strategic partnership building, and successful product launches throughout their career in the pharmaceutical industry.

Amir Nakash holds a Master of Science (MS) degree in Biotechnology & Entrepreneurship from New York University. Prior to that, they completed their Bachelor's degree in Biology at Brooklyn College. Additionally, Amir has a background in Immunology from Lund University.